Vitamin B12 (Cyanocobalamine) Injection

Composition:

• **Active Ingredient:** Cyanocobalamin (Vitamin B12)
• **Formulation:** Each mL of the injection typically contains:
• Cyanocobalamin: 1000 mcg (1 mg)
• **Excipients:** May include sodium chloride, water for injection, and other stabilizers or preservatives as required.

#### Dosages:

• **General Adult Dosage:**
• **Initial Treatment:** 1000 mcg (1 mg) intramuscularly (IM) or subcutaneously (SC) once a week for 4-6 weeks.
• **Maintenance Dose:** 1000 mcg (1 mg) IM or SC every month, or as directed by a healthcare provider.
• **Pediatric Dosage:**
• **Initial Treatment:** 30-100 mcg IM or SC, depending on the age and weight of the child, may be given once a week for 4-6 weeks.
• **Maintenance Dose:** 100-200 mcg IM or SC every month, or as directed by a healthcare provider.
• **Special Populations:**
• **Pregnant and Lactating Women:** Dosage should be determined by a healthcare provider based on individual needs.

#### Indications:

• **Vitamin B12 Deficiency:** Treatment of vitamin B12 deficiency due to malabsorption, dietary deficiency, or increased requirements (e.g., pregnancy).
• **Pernicious Anemia:** Management of pernicious anemia, a condition where the body cannot absorb vitamin B12 due to lack of intrinsic factor.
• **Neurological Disorders:** Used in certain neurological conditions associated with vitamin B12 deficiency, such as peripheral neuropathy.
• **Megaloblastic Anemia:** Treatment of megaloblastic anemia due to vitamin B12 deficiency.
• **Post-Surgical Patients:** Patients who have undergone gastrointestinal surgery that affects absorption may require supplementation.

#### Note:

• Dosage and administration should always be guided by a healthcare professional based on individual patient needs and clinical response.
• Monitor patients for signs of deficiency and adjust dosages accordingly.

Always refer to specific product labeling and guidelines for detailed information and consult a healthcare professional for personalized medical advice.